Ventrus Biosciences (VTUS) Files 949K Common Shelf for Shareholders
Tweet
Share
E-mailGet Alerts VTUS Hot Sheet
Join SI Premium – FREE
Ventrus Biosciences (Nasdaq: VTUS) filed a registration with the U.S. Securities and Exchange commission to sell, from time to time, up to 948,378 shares of Common Stock on behalf of Selling Shareholders.
Ventrus will not receive proceeds from the secondary offering.
Ventrus will not receive proceeds from the secondary offering.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Scribe Therapeutics prices IPO at $15 per share on Nasdaq
- Market Technology Acquisition Corp prices $200M IPO on Nasdaq
- Mapfre to acquire Safety Insurance Group in $1.54B all-cash deal
Create E-mail Alert Related Categories
Equity OfferingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
